An Impella device (Abiomed, Inc., Danvers, Massachusetts, United States) is a useful percutaneous left ventricular assist device for patients with cardiogenic shock. However, there are cases in which patients are unable to escape cardiogenic shock and become Impella-dependent. Long-term management can lead to thrombus. A man in his thirties experienced acute myocardial infarction necessitating Impella 5.5 support. Initially, a thrombus was not detected in the ascending aorta. Nonetheless, a mobile thrombus was observed post-Impella removal. His computed tomography revealed thrombosis in the iliac artery the following day. Diligent monitoring during Impella removal is imperative.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518699 | PMC |
http://dx.doi.org/10.7759/cureus.70399 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!